We are live on ! Find out more
ABG

Ally Bridge Group Portfolio holdings

AUM $124M
1-Year Est. Return 249.88%
This Fund
S&P 500
This Quarter Est. Return
+44.92%
1 Year Est. Return
+249.88%
3 Year Est. Return
+942.29%
5 Year Est. Return
+671.08%
10 Year Est. Return
AUM
$584M
AUM Growth
Cap. Flow
+$503M
Cap. Flow %
86.17%
Top 10 Hldgs %
71.5%
Holding
30
New
30
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 65.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDNY
26
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3.17M 0.54%
+199,600
New +$3.01M
ORTX
27
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.37M 0.41%
+54,743
New +$2.45M
ONCT
28
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.47M 0.25%
+15,000
New +$949K
EPIX
29
DELISTED
ESSA Pharma
EPIX
$933K 0.16%
+78,185
New +$550K
NSTG
30
DELISTED
NanoString Technologies, Inc.
NSTG
$620K 0.11%
+9,277
New +$465K

Similar funds

Ally Bridge Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Ally Bridge Group, which disclosed 30 positions worth $584M. Its ten largest holdings account for 72% of the portfolio.

Its largest position is MedAvail Holdings, Inc. Common Stock: 58,416 shares worth $44M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets.

  • Ally Bridge Group's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 58,416 shares worth $44M.
  • Ally Bridge Group's ten largest holdings make up 72% of its $584M portfolio in Q4 2020.
  • Ally Bridge Group disclosed 30 positions in Q4 2020, its first 13F filing on record.

Based on Ally Bridge Group's 13F filing for Q4 2020, filed 16 Feb 2021.